Giovanni Antonini


Titolo Pubblicato in Anno
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation FRONTIERS IN NEUROLOGY 2023
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 2023
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies EUROPEAN JOURNAL OF NEUROLOGY 2023
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study LANCET NEUROLOGY 2023
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early- access program in Italy EUROPEAN JOURNAL OF NEUROLOGY 2022
Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings AMYLOID 2022
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies JOURNAL OF NEUROLOGY 2022
Distal upper limb involvement in myasthenia-myositis association NEUROLOGICAL SCIENCES 2022
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures JOURNAL OF NEUROSURGICAL SCIENCES 2022
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score NEUROLOGY 2022
Benefit and danger from immunotherapy in myasthenia gravis NEUROLOGICAL SCIENCES 2021
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up JOURNAL OF NEUROLOGY 2021
A 5-year clinical follow-up study from the Italian National Registry for FSHD JOURNAL OF NEUROLOGY 2021
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension NEUROLOGY 2021
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy ORPHANET JOURNAL OF RARE DISEASES 2021
ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country GENES 2021
The neurophysiological lesson from the Italian CIDP database NEUROLOGICAL SCIENCES 2021
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP JOURNAL OF NEUROLOGY 2021
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation NEUROLOGICAL SCIENCES 2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial LANCET NEUROLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma